GE Healthcare Introduces StarGuide, a New Nuclear Medicine System to Help Advance Precision Health & Theranostics

[FOR EUROPEAN MEDIA] GE Healthcare introduces StarGuide, the company’s most advanced SPECT/CT designed to usher in a new age of discovery for research-focused clinicians Utilizing the latest advancements in Cadmium Zinc Telluride (CZT) technology, StarGuide helps providers explore and better understand the patient condition to improve patient outcomes across care areas The system’s Digital Focus... Read more

GE Healthcare Introduces StarGuide, a New Nuclear Medicine System to Help Advance Precision Health & Theranostics

[FOR EUROPEAN MEDIA] GE Healthcare introduces StarGuide, the company’s most advanced SPECT/CT designed to usher in a new age of discovery for research-focused clinicians Utilizing the latest advancements in Cadmium Zinc Telluride (CZT) technology, StarGuide helps providers explore and better understand the patient condition to improve patient outcomes across care areas The system’s Digital Focus... Read more

GE Healthcare Announces 510(k) Clearance of New 3D Surgical Imaging System, Enabling More Precise and Efficient Care

New 3D/2D surgical imaging system, OEC 3D, brings precise 3D and 2D imaging to surgical suites improving efficiency Salt Lake City – March 23, 2021 – GE Healthcare today announced 510(k) clearance from U.S. FDA for OEC 3D, a new surgical imaging system capable of 3D and 2D imaging. OEC 3D will set a standard... Read more

Roche launches new high throughput configurations for cobas pro integrated solutions to increase testing efficiency

With eight new configurations, cobas pro® integrated solutions offers labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needs This will allow a greater number of patient samples to be processed faster By consolidating up to four analytical units on a single platform, testing efficiency in high-volume labs is increased... Read more

New phase III data shows investigational antibody cocktail casirivimab and imdevimab reduced hospitalisation or death by 70% in non-hospitalised patients with COVID-19

Investigational antibody cocktail of casirivimab and imdevimab also significantly shortened the duration of symptoms by four days The 2,400 mg and 1,200 mg doses tested in the phase III study had similar efficacy across all endpoints Companion dose-ranging phase II trial showed significant and comparable viral reductions for a range of doses of casirivimab and... Read more

Thermo Fisher Scientific Announces New Human Plasma-Like Cell Culture Medium

First-of-its-kind medium resembles the natural cellular environment found in the human body for more physiologically relevant cell culture models CARLSBAD, Calif., March 22, 2021 /PRNewswire/ — Thermo Fisher Scientific today launched the new Gibco Human Plasma-like Medium (HPLM), the first cell culture medium on the market that mimics the metabolic profile of human plasma that... Read more

PerkinElmer Launches Industry-First CRM Reagent and Consumable Kit to Streamline Cannabis Pesticide Testing Workflows

ONE Pesticide420™ solution delivers enhanced cannabis & hemp testing experience with 70+ ready-to-use certified calibration levels WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today launched its ONE Pesticide420™ CRM Reagent and Consumable Kit for cannabis & hemp testing. Initially the kits will support pesticide and mycotoxin testing for cannabis &... Read more

Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics

Acuity Technology Enables the Possibility to See the 3D Genome in situ and at Single-Cell and Sub-Cellular Resolution SAN JOSE, Calif. & BOSTON–(BUSINESS WIRE)– Acuity Spatial Genomics, Inc. today announced the completion of a majority investment by Bruker Corporation (Nasdaq: BRKR). Acuity is a new venture focused on opening a new frontier in spatial 3D... Read more